Drug lookup
Drug reference

Niclosamide

Anthelmintic · Treatment for tapeworm infections (Taenicide)

AnthelminticTreatment for tapeworm infections (Taenicide)ATC null
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
1 major
SEVERE in our sources
PREGNANCY
X
FDA category + note
Top interactions
  • TizanidineSevereDatabaseDDInter

Mechanism

Niclosamide is a halogenated salicylanilide that kills cestodes (tapeworms) by uncoupling oxidative phosphorylation in mitochondria, inhibiting ATP generation, and stimulating ATPase activity. This disrupts the worm's energy metabolism, causing damage to the tegument (outer covering) and making the scolex susceptible to proteolytic digestion. It is active only against adult cestodes in the intestinal lumen — not against ova or larvae — and achieves cure rates exceeding 85% for Diphyllobothrium latum and 95% for Taenia saginata.

Indications

Tapeworm infectionsintestinal Taenia solium infectionTaenia saginataTaenia soliumDiphyllobothrium latumHymenolepis nanaPin wormTaenia solium infection

Dosing

Adult
T. saginata/D. latum: 2 g as a single dose (chewed thoroughly on empty stomach). solium: 2 g as a single dose followed by a purgative 2 hours later to prevent cysticercosis.
Pediatric
2-6 years: 1 g single dose. >6 years: adult dose.
Max dose
2 g single dose

Pharmacokinetics

Bioavailability
Minimally absorbed from g.i.t.

Side effects

Common
NauseaLightheadednessAbdominal painPruritusMinor abdominal symptoms (occasionally)Malaise (rare)Pruritus (rare)Light headedness (rare)vomitingdizziness

Pregnancy & lactation

Pregnancy

X

Drug interactions

Tizanidine
Severe
Database

Clinical effect not specified

Source: DDInter

5 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Anthelmintic drugs

Ask House about Niclosamide

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, BNF·Verified: 2026-05-13 · House clinical team